Tower Research Capital LLC (TRC) - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 97 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,641
+2.7%
6,760
+37.9%
0.00%
Q2 2023$12,304
+34077.8%
4,902
-76.5%
0.00%
-100.0%
Q1 2023$36
-68.7%
20,874
-22.9%
0.00%
-80.0%
Q4 2022$115
-99.2%
27,080
+137.7%
0.01%
Q3 2022$14,000
+55.6%
11,391
+21.7%
0.00%
Q2 2022$9,000
-10.0%
9,363
+124.2%
0.00%
Q1 2022$10,000
-9.1%
4,176
+2.3%
0.00%
Q4 2021$11,000
-8.3%
4,081
+73.0%
0.00%
Q3 2021$12,000
-53.8%
2,359
-31.3%
0.00%
-100.0%
Q2 2021$26,000
-7.1%
3,436
-28.7%
0.00%
Q1 2021$28,000
+55.6%
4,817
+27.3%
0.00%
-100.0%
Q4 2020$18,0003,7830.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders